{"name": "Gentronix",
 "permalink": "gentronix",
 "crunchbase_url": "http://www.crunchbase.com/company/gentronix",
 "homepage_url": "http://www.gentronix.co.uk",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "44-(0)-161-603-7676",
 "description": "",
 "created_at": "Thu Mar 18 07:41:08 UTC 2010",
 "updated_at": "Thu Mar 18 07:49:40 UTC 2010",
 "overview": "\u003Cp\u003Egentronix provides services and solutions that help companies reduce attrition rates and ensure safer products across a wide range of chemistry driven industries.\u003C/p\u003E\n\n\u003Cp\u003ETheir primary focus is on providing better hazard identification assays for genotoxicity through the use of their patented human cell GADD45a reporter assays GreenScreen\u00c2\u00ae HC and BlueScreen HC.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       42],
      "assets/images/resized/0008/0775/80775v1-max-150x150.jpg"],
     [[250,
       70],
      "assets/images/resized/0008/0775/80775v1-max-250x250.jpg"],
     [[409,
       116],
      "assets/images/resized/0008/0775/80775v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "\u00a31M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.gentronix.co.uk/News/PressReleases/NVMInvestment/tabid/92/Default.aspx",
    "source_description": "NVM invests in Pioneering Drug Safety Testing Company",
    "raised_amount": 1000000.0,
    "raised_currency_code": "GBP",
    "funded_year": 2007,
    "funded_month": 3,
    "funded_day": 5,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "NVM Private Equity",
         "permalink": "nvm-private-equity",
         "image":
          {"available_sizes":
            [[[150,
               92],
              "assets/images/resized/0008/0781/80781v2-max-150x150.png"],
             [[164,
               101],
              "assets/images/resized/0008/0781/80781v2-max-250x250.png"],
             [[164,
               101],
              "assets/images/resized/0008/0781/80781v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "CTF Building",
    "address2": "46 Grafton Street",
    "zip_code": "M13 9NT",
    "city": "Manchester",
    "state_code": null,
    "country_code": "GBR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        132],
       "assets/images/resized/0008/0776/80776v1-max-150x150.jpg"],
      [[250,
        221],
       "assets/images/resized/0008/0776/80776v1-max-250x250.jpg"],
      [[450,
        398],
       "assets/images/resized/0008/0776/80776v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}